Epidemiology of community acquired pneumonia

Logan Manikam; Monica Lakhanpaul

doi:10.1016/j.paed.2012.05.002

Epidemiology of community acquired pneumonia

Paediatr Child Health (Oxford). 2012 Jul;22(7):299-306. doi: 10.1016/j.paed.2012.05.002. Epub 2012 Jun 25.

Authors

Logan Manikam^{1

2}, Monica Lakhanpaul^{1

2}

Affiliations

¹ is an Academic Clinical Fellow in Paediatrics, Imperial College London, UK. Conflicts of interest: none declared.
² is Professor of Integrated Community Child Health, UCL Institute of Child Health, London, UK. Conflicts of interest: none declared.

Abstract

Despite efforts in prevention worldwide including recent advances in vaccine therapy, childhood community acquired pneumonia (CAP) remains a major cause of morbidity and mortality both in the developed and the developing world. Traditionally, qualifying the aetiology of CAP proved to be fraught with challenges particularly due to low yields from blood and sputum specimens. In recent years however, new advances in techniques such as enzyme-linked immunosorbent assay and polymerase chain reaction have dramatically improved detection rates of both bacteria and viruses. In addition to qualifying the true burden of disease by known organisms such as Streptococcus pneumoniae it has led to the identification of organisms such as human bocavirus which have not previously been associated with CAP. This article aims to provide a brief update to the clinician on the current epidemiology of CAP in this post-vaccination era. It is based on a combination of recommendations from existing clinical practice guidelines, recent systematic reviews and the current literature.

Keywords: children; community acquired pneumonia; epidemiology; guidelines; infection; prevalence.

Publication types

Review